TRANSLATIONAL MEDICINE 2017 is the third bi-annual conference organised by EATRIS. This event, open to a wide range of stakeholders (pharma industry, academia, research funders), will bring together experts and key actors in translational research, to discuss current approaches and future perspectives in the field.
The theme of this third edition will be “Enhancing Predictivity in Medicines Development” and will focus on bringing together the latest approaches to increase chances of success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification.
The conference will start on Sunday, September 24 with a series of educational workshops. The workshops will be dedicated to key topics in the field such as molecular imaging, biomarker validation or potency assays for ATMP’s and vaccines.
For the main conference on September 25 and 26, the event will be structured around 3 plenary sessions, introduced by keynote speakers:
Session 1: The Funder, Developer and Regulator as Partners in Innovation
Session 2: Novel approaches in clinical development
Session 3: Developing more predictive preclinical tools to better reach proof of concept
More information on the programme
Early bird registration until May 15